Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IGEN International -- Ignore unavailable to you. Want to Upgrade?

To: John Bernhardt who wrote (502)	5/13/1999 12:55:00 AM
From: James Perry	Respond to of 1025

Hey, did people over here miss the conference call recorded on V Call on May 11? George McGusky, the CFO, mentioned that Igen has a 40 man sales force that is about 2/3 trained and will institute placement of the high throughput machine without cost on a periodic contract for $100,000 in operating supplies. (You remember: Sam said it - like at Gillette, it ain't the razors, its the blades!) By June he anticipated production would be at 25 per month. Also he noted that the lawsuit was scheduled for early next year and he "certainly hoped it would be settled before that time". He said (at a different point) that the 300 sales which Roche was ordered to turn over to Igen by the court would be delivered "in 30 days. Or less". And he said "good productive settlement talks" were going on. He hinted that the ability to get a 30 million loan from John Hancock at reasonable interest and without stock, warrants or other inducements, had certainly aided the settlement climate! I have been waiting for this stock to mature since it was $5, and I am not out of patience but I think we are about to be off on a rocket ride.